SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) September 10, 2004
MEDIFAST, INC.
(Exact name of registrant as specified in its charter)
Delaware 000-23016 13-3714405
--------------------------- ---------------------- ----------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation or organization) Ident. No.)
11445 Cronhill Drive, Owing Mills, Maryland 21117
------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (410)-581-8042
--------------
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
-------------------------------------------------------------
-------------------------------------------------------------
Item 8.01 Other Events
The Medifast Annual Shareholders Meeting was held on September 3, 2004 at
Sunrise Distributing, the Company's distribution headquarters. The shareholders
voted Bradley T. MacDonald (98%) and Rev. Donald F. Reilly, O.S.A.* (98%) as
Class I Directors that will hold office until 2007, Scott Zion* (98%) and
Michael C. MacDonald (98%) as Class II Directors, and Mary T. Travis* (98%),
Michael J. McDevitt (98%), and Rev. Joseph Calderone, O.S.A.* (98%) as Class III
Directors. Class II and III Directors will hold office until the next Annual
Shareholders Meeting at which time their respective class term expires and their
respective successors will be duly elected and qualified. Additionally, the
shareholders approved the appointment of Bagell, Josephs & Company, LLC, an
independent member of the BDO Seidman Alliance, as the Company's independent
auditors for the fiscal year ending December 31, 2004.
The Directors elected Mr. Bradley T. MacDonald as Chairman of the Board
and CEO of Medifast, Inc.
* Independent Director; independence as determined by the rules of the
American Stock Exchange.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDIFAST, INC.
Dated: September 10, 2004
/s/ Bradley T. MacDonald
--------------------------------------
Bradley T. MacDonald
Chairman and Chief Executive Officer